OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
7
Results
Show all
Save search
Copy query
Show results for
Unknown
(7)
Publication Date
Release Date
2023
(3)
2025
(2)
2024
(1)
2018
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Successful outcomes for patients with drug-resistant tuberculosis despite civil unrest and COVID-19 in Haiti.
Not available
S-EPMC10497149
|
biostudies-literature
Cite
Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications.
Not available
S-EPMC10237267
|
biostudies-literature
Cite
Effectiveness of a bedaquiline, linezolid, clofazimine 'core' for multidrug-resistant TB.
Not available
S-EPMC12068452
|
biostudies-literature
Cite
Estimating Post-treatment Recurrence After Multidrug-Resistant Tuberculosis Treatment Among Patients With and Without Human Immunodeficiency Virus: The Impact of Assumptions About Death and Missing Follow-up.
Not available
S-EPMC10810712
|
biostudies-literature
Cite
Comparative effectiveness of adding delamanid to a multidrug-resistant tuberculosis regimen comprised of three drugs likely to be effective.
Not available
S-EPMC10146539
|
biostudies-literature
Cite
The Frequency and Incidence of QT Prolongation With Extended Use of Bedaquiline or Delamanid in a Large, Multi-Country Multidrug-Resistant/Rifampicin-Resistant Tuberculosis Cohort.
Not available
S-EPMC12314499
|
biostudies-literature
Cite
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.
Not available
S-EPMC6463280
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets